● Recruiting

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Condition: Non-small Cell Lung Cancer · Sponsor: Bristol-Myers Squibb

PhasePhase 3

Planned participants1000

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (320)

Local Institution - 0487	Mobile, Alabama, United States	Not Yet Recruiting
Southern Arizona VA Health Care System	Tucson, Arizona, United States	Recruiting
Local Institution - 0112	Los Angeles, California, United States	Withdrawn
University of California Davis (UC Davis) Comprehensive Cancer Center	Sacramento, California, United States	Recruiting
San Francisco Oncology Associates	San Francisco, California, United States	Recruiting
UCLA Hematology/Oncology - Santa Monica	Santa Monica, California, United States	Recruiting
Local Institution - 0500	Grand Junction, Colorado, United States	Not Yet Recruiting
Local Institution - 0472	Westminster, Colorado, United States	Not Yet Recruiting
University of Miami Hospital and Clinics, Sylvester Cancer Center	Miami, Florida, United States	Recruiting
Memorial Hospital West	Pembroke Pines, Florida, United States	Recruiting
Florida Cancer Specialists - North	St. Petersburg, Florida, United States	Recruiting
Local Institution - 0477	Tamarac, Florida, United States	Not Yet Recruiting

+ 308 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06561386